COO

Companies
NASDAQ
The Cooper Companies Inc.
Health Care
Price Chart
Overview

About COO

The Cooper Companies is one of the largest eye care companies in the U.S. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business and is composed of a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and clariti, Cooper controls roughly a quarter of the U.S. contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the U.S., and controls 17% of the U.S. IUD market.

Market Cap
$18.8B
Volume
139.7M
Avg. Volume
161.3M
P/E Ratio
18.237747
Dividend Yield
0.08%
Employees
7.7K

Company Information

Exchange
NASDAQ
Sector
Health Care
Industry
Medical Instruments & Supplies
Risk & Correlation Analysis
Market Correlation
0.38
Low Correlation
Volatility
Medium (0.26)
Relative to market

Macro Factor Sensitivities

Interest Rates
Medium Sensitivity
Inflation
Medium Sensitivity
GDP Growth
Low Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
Medium Sensitivity
Portfolio Impact
Forecasts & Predictions

Premium Forecasts

Get AI-powered price predictions, technical analysis, and market forecasts for COO.

1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential

Technical Analysis

Based on technical indicators and chart patterns, COO shows...

AI Sentiment Analysis

Market sentiment analysis indicates...

Key Statistics
Market Cap$18.8B
Volume139.7M
P/E Ratio18.24
Dividend Yield0.08%
Important Dates
Next Dividend
August 11, 2023
Next Earnings
March 7, 2025

PortfolioPilot Analysis

Get AI-powered insights on how COO fits into your investment strategy and portfolio diversification.

Pricing info last updated June 17, 2025 (after market close)Other info last updated April 2, 2025